A Flash-Induced Robust Cu Electrode on Glass Substrates and Its Application for Thin-Film μLEDs
Black-Box Optimization for Automated Discovery
ConspectusIn chemistry and supplies science, researchers and engineers uncover, design, and optimize chemical compounds or supplies with their skilled information and strategies. At the very best stage of abstraction, this course of is formulated as black-box optimization. For occasion, the trial-and-error course of of synthesizing numerous molecules for higher materials properties could be thought to be optimizing a black-box perform describing the relation between a chemical system and its properties.
Various black-box optimization algorithms have been developed within the machine studying and statistics communities. Recently, plenty of researchers have reported profitable functions of such algorithms to chemistry. They embrace the design of photofunctional molecules and medical medicine, optimization of thermal emission supplies and excessive Li-ion conductive strong electrolytes, and discovery of a brand new part in inorganic skinny movies for photo voltaic cells.
There are all kinds of algorithms accessible for black-box optimization, comparable to Bayesian optimization, reinforcement studying, and lively studying. Practitioners want to pick an acceptable algorithm or, in some circumstances, develop novel algorithms to fulfill their calls for. It can also be vital to find out tips on how to finest mix machine studying strategies with quantum mechanics- and molecular mechanics-based simulations, and experiments. In this Account, we give an summary of latest research relating to automated discovery, design, and optimization based mostly on black-box optimization.
The Account covers the next algorithms: Bayesian optimization to optimize the chemical or bodily properties, an optimization methodology utilizing a quantum annealer, best-arm identification, gray-box optimization, and reinforcement studying. In addition, we introduce lively studying and boundless objective-free exploration, which can not fall into the class of black-box optimization.Data high quality and amount are key for the success of those automated discovery strategies. As laboratory automation and robotics are put ahead, automated discovery algorithms would be capable of match human efficiency at the least in some domains within the close to future.
The Emergence of RNA from the Heterogeneous Products of Prebiotic Nucleotide Synthesis
Recent advances in prebiotic chemistry are starting to stipulate believable pathways for the synthesis of the canonical ribonucleotides and their meeting into oligoribonucleotides. However, these response pathways counsel that many noncanonical nucleotides are more likely to have been generated alongside the usual ribonucleotides. Thus, the oligomerization of prebiotically synthesized nucleotides is more likely to have led to a extremely heterogeneous assortment of oligonucleotides comprised of a variety of forms of nucleotides linked by a wide range of spine linkages.
Human CCL4 Recombinant Protein |
|||
R00703-3 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Human CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
Recombinant Human MIP-1 beta/CCL4 |
|||
HECCP-0401 | Cyagen | 10ug | Ask for price |
Recombinant Human CCL4/MIP-1β Protein |
|||
RP01654 | Abclonal | 20μg | EUR 195 |
Recombinant Rat CCL4 |
|||
6567 | Immunochemistry | 5 µg | EUR 194 |
Recombinant Rat CCL4 |
|||
RECCP-0401 | Cyagen | 5ug | Ask for price |
Recombinant Mouse CCL4 |
|||
6568 | Immunochemistry | 5 µg | EUR 194 |
Recombinant Murine CCL4 |
|||
MECCP-0401 | Cyagen | 10ug | Ask for price |
CCL4 Recombinant Protein |
|||
90-380 | ProSci | 10 ug | EUR 405.6 |
Description: CCL4, (C-C motif chemokine 4; macrophage inflammatory protein 1beta) is a chemokine secreted at sites of inflammation by activated leukocytes, lymphocytes, vascular endothelial cells and pulmonary smooth cells. CCL4 attracts a variety of immune cells to sites of microbial infection as well as to pathologic inflammation, such as allergic asthma and ischemic myocardium. Full-length and truncated CCL4 exert biological activity through the receptor CCR5. The truncated form of CCL4 interacts additionally with CCR1 and CCR2b. The ability of CCL4 to bind CCR5 inhibits the cellular entry of M-tropic HIV. Both CCL4 forms block HIV-1 infection of T cells by inducing the downregulation of CCR5. |
CCL4 Recombinant Protein |
|||
90-381 | ProSci | 50 ug | EUR 519 |
Description: CCL4, (C-C motif chemokine 4; macrophage inflammatory protein 1beta) is a chemokine secreted at sites of inflammation by activated leukocytes, lymphocytes, vascular endothelial cells and pulmonary smooth cells. CCL4 attracts a variety of immune cells to sites of microbial infection as well as to pathologic inflammation, such as allergic asthma and ischemic myocardium. Full-length and truncated CCL4 exert biological activity through the receptor CCR5. The truncated form of CCL4 interacts additionally with CCR1 and CCR2b. The ability of CCL4 to bind CCR5 inhibits the cellular entry of M-tropic HIV. Both CCL4 forms block HIV-1 infection of T cells by inducing the downregulation of CCR5. |
Recombinant Human MIP-1 Beta (CCL4) Protein |
|||
PROTQ8NHW4-2 | BosterBio | 10ug | EUR 380.4 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant human MIP-1βis a 7.6 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Human CCL4 Recombinant Protein Fc Tag Lyophilized |
|||
IHUCCL4RFCLY10UG | Innovative research | each | EUR 438 |
Description: Human CCL4 Recombinant Protein Fc Tag Lyophilized |
Human CCL4 Recombinant Protein Fc Tag Lyophilized |
|||
IHUCCL4RFCLY50UG | Innovative research | each | EUR 592 |
Description: Human CCL4 Recombinant Protein Fc Tag Lyophilized |
Rat CCL4 Recombinant Protein |
|||
R00703-6 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Rat CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-5ug |
|||
QP10227-ec-5ug | EnQuireBio | 5ug | EUR 184.8 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-2ug |
|||
QP10228-ec-2ug | EnQuireBio | 2ug | EUR 184.8 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-1mg |
|||
QP5256-1mg | EnQuireBio | 1mg | EUR 3427.2 |
Mouse CCL4 Recombinant Protein |
|||
R00703-4 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Mouse CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
Swine CCL4 Recombinant Protein |
|||
R00703-7 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Swine CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-20ug |
|||
QP10227-ec-20ug | EnQuireBio | 20ug | EUR 348 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-10ug |
|||
QP10228-ec-10ug | EnQuireBio | 10ug | EUR 348 |
Bovine CCL4 Recombinant Protein |
|||
R00703 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Bovine CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
Canine CCL4 Recombinant Protein |
|||
R00703-1 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Canine CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
Rabbit CCL4 Recombinant Protein |
|||
R00703-5 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Rabbit CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-100ug |
|||
QP10227-ec-100ug | EnQuireBio | 100ug | EUR 1185.6 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-250ug |
|||
QP10227-ec-250ug | EnQuireBio | 250ug | EUR 2077.2 |
Recombinant Human CCL4/ MIP1B Protein, Untagged, E.coli-500ug |
|||
QP5256-500ug | EnQuireBio | 500ug | EUR 2133.6 |
Chicken CCL4 Recombinant Protein |
|||
R00703-2 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Chicken CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast. |
Porcine Chemokine CCL4 Recombinant |
|||
IPCCCL4R25UG | Innovative research | each | EUR 482 |
Description: Porcine Chemokine CCL4 Recombinant |
Porcine Chemokine CCL4 Recombinant |
|||
IPCCCL4R5UG | Innovative research | each | EUR 283 |
Description: Porcine Chemokine CCL4 Recombinant |
Recombinant Rat MIP-1? (CCL4) |
|||
4249-20 | Biovision | each | EUR 332.4 |
Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
7-02020 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
7-02021 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
7-02022 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Macrophage Inflammatory Protein-1 beta/CCL4 |
|||
AP60299 | SAB | 100ug | EUR 896 |
Human Macrophage Inflammatory Protein-1 beta (CCL4) , (Recombinant) |
|||
22060541-1 | Bio-WORLD | 2 µg | EUR 146.42 |
Recombinant Human C-C motif chemokine 4 protein (CCL4) (Active) |
|||
CSB-AP000861HU | Cusabio | 8352 mg | Ask for price |
Recombinant Human C-C motif chemokine 4 protein(CCL4) (Active) |
|||
AP73309 | SAB | 1mg | EUR 3939 |
Recombinant Human C-C motif chemokine 4 protein(CCL4) (Active) |
|||
AP73310 | SAB | 1mg | EUR 3939 |
OPCD05280-10UG - CCL4 Recombinant Protein |
|||
OPCD05280-10UG | Aviva Systems Biology | 10ug | EUR 149 |
OPCD05280-50UG - CCL4 Recombinant Protein |
|||
OPCD05280-50UG | Aviva Systems Biology | 50ug | EUR 359 |
OPCD05281-10UG - CCL4 Recombinant Protein |
|||
OPCD05281-10UG | Aviva Systems Biology | 10ug | EUR 149 |
OPCD05281-50UG - CCL4 Recombinant Protein |
|||
OPCD05281-50UG | Aviva Systems Biology | 50ug | EUR 379 |
OPCD05282-10UG - CCL4 Recombinant Protein |
|||
OPCD05282-10UG | Aviva Systems Biology | 10ug | EUR 119 |
OPCD05282-50UG - CCL4 Recombinant Protein |
|||
OPCD05282-50UG | Aviva Systems Biology | 50ug | EUR 289 |
OPCD05283-10UG - CCL4 Recombinant Protein |
|||
OPCD05283-10UG | Aviva Systems Biology | 10ug | EUR 149 |
OPCD05283-50UG - CCL4 Recombinant Protein |
|||
OPCD05283-50UG | Aviva Systems Biology | 50ug | EUR 369 |
OPCD05284-10UG - CCL4 Recombinant Protein |
|||
OPCD05284-10UG | Aviva Systems Biology | 10ug | EUR 159 |
OPCD05284-50UG - CCL4 Recombinant Protein |
|||
OPCD05284-50UG | Aviva Systems Biology | 50ug | EUR 379 |
OPCD05285-10UG - CCL4 Recombinant Protein |
|||
OPCD05285-10UG | Aviva Systems Biology | 10ug | EUR 129 |
OPCD05285-50UG - CCL4 Recombinant Protein |
|||
OPCD05285-50UG | Aviva Systems Biology | 50ug | EUR 309 |
OPCD05280-200UG - CCL4 Recombinant Protein |
|||
OPCD05280-200UG | Aviva Systems Biology | 200ug | EUR 719 |
OPCD05281-200UG - CCL4 Recombinant Protein |
|||
OPCD05281-200UG | Aviva Systems Biology | 200ug | EUR 749 |
OPCD05282-200UG - CCL4 Recombinant Protein |
|||
OPCD05282-200UG | Aviva Systems Biology | 200ug | EUR 579 |
OPCD05283-200UG - CCL4 Recombinant Protein |
|||
OPCD05283-200UG | Aviva Systems Biology | 200ug | EUR 729 |
OPCD05284-200UG - CCL4 Recombinant Protein |
|||
OPCD05284-200UG | Aviva Systems Biology | 200ug | EUR 759 |
OPCD05285-200UG - CCL4 Recombinant Protein |
|||
OPCD05285-200UG | Aviva Systems Biology | 200ug | EUR 609 |
Recombinant (E.Coli) Human Macrophage Inflammatory protein-1 beta (CCL4) |
|||
RP-1009 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Recombinant Rat MIP-1 Beta (CCL4) Protein |
|||
PROTP50230-1 | BosterBio | 20ug | EUR 380.4 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant rat MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Recombinant Murine MIP-1 Beta (CCL4) Protein |
|||
PROTP14097-1 | BosterBio | 10ug | EUR 380.4 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant murine MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
OPSD00070-2UG - Recombinant MIP-1 beta / CCL4 |
|||
OPSD00070-2UG | Aviva Systems Biology | 2ug | EUR 108 |
OPSD00131-2UG - Recombinant MIP-1 beta / CCL4 |
|||
OPSD00131-2UG | Aviva Systems Biology | 2ug | EUR 108 |
Recombinant Mouse C-C motif chemokine 4 (Ccl4) |
|||
RPC28325-100ug | Biomatik Corporation | 100ug | EUR 635.8 |
Recombinant Mouse C-C motif chemokine 4 (Ccl4) |
|||
RPC28325-1mg | Biomatik Corporation | 1mg | EUR 2885.2 |
Recombinant Mouse C-C motif chemokine 4 (Ccl4) |
|||
RPC28325-20ug | Biomatik Corporation | 20ug | EUR 353.4 |
Recombinant Mouse C-C motif chemokine 4 (Ccl4) |
|||
CSB-EP004797MO | Cusabio | 5261 mg | Ask for price |
Recombinant Mouse C-C motif chemokine 4(Ccl4) |
|||
AP77565 | SAB | 1mg | EUR 2826 |
MIP-1b Macrophage Inflammatory Protein-1 Beta Human Recombinant Protein (CCL4) |
|||
PROTP13236 | BosterBio | Regular: 10ug | EUR 380.4 |
Description: Macrophage Inflammatory Protein-1 beta Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 69 amino acids and having a molecular mass of 7620 Dalton. ;The CCL4 is purified by proprietary chromatographic techniques. |
Recombinant Rat CCL4/ MIP1B Protein, Untagged, E.coli-5ug |
|||
QP10293-ec-5ug | EnQuireBio | 5ug | EUR 184.8 |
Recombinant Rat CCL4/ MIP1B Protein, Untagged, E.coli-20ug |
|||
QP10293-ec-20ug | EnQuireBio | 20ug | EUR 348 |
Recombinant Mouse CCL4/ MIP1B Protein, Untagged, E.coli-2ug |
|||
QP10264-ec-2ug | EnQuireBio | 2ug | EUR 184.8 |
Recombinant Rat CCL4/ MIP1B Protein, Untagged, E.coli-100ug |
|||
QP10293-ec-100ug | EnQuireBio | 100ug | EUR 1185.6 |
Recombinant Rat CCL4/ MIP1B Protein, Untagged, E.coli-250ug |
|||
QP10293-ec-250ug | EnQuireBio | 250ug | EUR 2077.2 |
Recombinant Mouse CCL4/ MIP1B Protein, Untagged, E.coli-1mg |
|||
QP5452-1mg | EnQuireBio | 1mg | EUR 3427.2 |
Recombinant Mouse CCL4/ MIP1B Protein, Untagged, E.coli-10ug |
|||
QP10264-ec-10ug | EnQuireBio | 10ug | EUR 348 |
Recombinant Mouse CCL4/ MIP1B Protein, Untagged, E.coli-100ug |
|||
QP10264-ec-100ug | EnQuireBio | 100ug | EUR 1185.6 |
Recombinant Mouse CCL4/ MIP1B Protein, Untagged, E.coli-250ug |
|||
QP10264-ec-250ug | EnQuireBio | 250ug | EUR 2077.2 |
Recombinant Mouse CCL4/ MIP1B Protein, Untagged, E.coli-500ug |
|||
QP5452-500ug | EnQuireBio | 500ug | EUR 2133.6 |
Recombinant Rat Macrophage Inflammatory Protein-1 beta/CCL4 |
|||
AP60377 | SAB | 100ug | EUR 896 |
Recombinant Mouse Macrophage Inflammatory protein-1 beta (CCL4) |
|||
7-02023 | CHI Scientific | 2µg | Ask for price |
Recombinant Mouse Macrophage Inflammatory protein-1 beta (CCL4) |
|||
7-02024 | CHI Scientific | 10µg | Ask for price |
Recombinant Mouse Macrophage Inflammatory protein-1 beta (CCL4) |
|||
7-02025 | CHI Scientific | 1mg | Ask for price |
Mouse Macrophage Inflammatory Protein-1 beta (CCL4) , (Recombinant) |
|||
22060542-1 | Bio-WORLD | 2 µg | EUR 146.42 |
Recombinant Murine Macrophage Inflammatory Protein-1 beta/CCL4 |
|||
AP60346 | SAB | 100ug | EUR 896 |
Recombinant Rat C-C motif chemokine 4 protein (Ccl4) (Active) |
|||
CSB-AP001531RA | Cusabio | 8416 mg | Ask for price |
Recombinant Rat C-C motif chemokine 4 protein(Ccl4) (Active) |
|||
AP73312 | SAB | 1mg | EUR 3939 |
Recombinant Mouse C-C motif chemokine 4 protein (Ccl4) (Active) |
|||
CSB-AP001231MO | Cusabio | 8387 mg | Ask for price |
Recombinant Mouse C-C motif chemokine 4 protein(Ccl4) (Active) |
|||
AP73311 | SAB | 1mg | EUR 3939 |
Recombinant Human CCL11 |
|||
P0165 | FN Test | 100ug | EUR 626.83 |
Description: Recombinant Human protein for CCL11 |
Recombinant Human CCL21 |
|||
Z100195 | ABM | 20 µg | EUR 85 |
Description: CCL21, which is a member of the family of CC-Chemokines, has a unique 36 (murine) or 37 (human) amino acid carboxyl-terminal extension not seen in other chemokines. CCL21 selectively stimulates the chemotaxis of adult T lymphocytes and is expressed preferentially in lymph node tissue. CCL21 is critical for adult T cell adhesion to high endothelial venules in lymph nodes, a rate-limiting step for T cell trafficking through nodal tissue. |
Recombinant Human CCL21 |
|||
Z100197 | ABM | 100 µg | EUR 295 |
Description: CCL21, which is a member of the family of CC-Chemokines, has a unique 36 (murine) or 37 (human) amino acid carboxyl-terminal extension not seen in other chemokines. CCL21 selectively stimulates the chemotaxis of adult T lymphocytes and is expressed preferentially in lymph node tissue. CCL21 is critical for adult T cell adhesion to high endothelial venules in lymph nodes, a rate-limiting step for T cell trafficking through nodal tissue. |
Recombinant Human CCL21 |
|||
Z100199 | ABM | 1.0 mg | EUR 2025 |
Description: CCL21, which is a member of the family of CC-Chemokines, has a unique 36 (murine) or 37 (human) amino acid carboxyl-terminal extension not seen in other chemokines. CCL21 selectively stimulates the chemotaxis of adult T lymphocytes and is expressed preferentially in lymph node tissue. CCL21 is critical for adult T cell adhesion to high endothelial venules in lymph nodes, a rate-limiting step for T cell trafficking through nodal tissue. |
Recombinant Human CCL22 |
|||
Z101015 | ABM | 20 µg | EUR 175 |
Description: CCL22 (monocyte-derived chemokine) was described initially as a constitutively produced, thymus-specific chemokine, implicated in the recruitment of T cells . One of the functions of CCL22 originally described was induction of migration of CCR4+ Th2 cells, but it has additionally been shown to regulate migration of Tregs. CCL22 has been implicated in a number of diseases, including allergen-induced lung inflammation, atopic dermatitis, and lymphoma. Similarly, a presumed role for CCR4+ cells has been suggested for endotoxic shock, rheumatoid arthritis, T cell lymphoma, and autoimmune diabetes |
Recombinant Human CCL22 |
|||
Z101017 | ABM | 5 x 20 µg (Z101015 x 5) | EUR 960 |
Description: CCL22 (monocyte-derived chemokine) was described initially as a constitutively produced, thymus-specific chemokine, implicated in the recruitment of T cells . One of the functions of CCL22 originally described was induction of migration of CCR4+ Th2 cells, but it has additionally been shown to regulate migration of Tregs. CCL22 has been implicated in a number of diseases, including allergen-induced lung inflammation, atopic dermatitis, and lymphoma. Similarly, a presumed role for CCR4+ cells has been suggested for endotoxic shock, rheumatoid arthritis, T cell lymphoma, and autoimmune diabetes |
Recombinant Human CCL22 |
|||
Z101019 | ABM | 1.0 mg | EUR 3900 |
Description: CCL22 (monocyte-derived chemokine) was described initially as a constitutively produced, thymus-specific chemokine, implicated in the recruitment of T cells . One of the functions of CCL22 originally described was induction of migration of CCR4+ Th2 cells, but it has additionally been shown to regulate migration of Tregs. CCL22 has been implicated in a number of diseases, including allergen-induced lung inflammation, atopic dermatitis, and lymphoma. Similarly, a presumed role for CCR4+ cells has been suggested for endotoxic shock, rheumatoid arthritis, T cell lymphoma, and autoimmune diabetes |
Recombinant Human CCL25 |
|||
Z101525 | ABM | 20 µg | EUR 235 |
Description: CCL25 is constitutively expressed in epithelium and mucosal vessels in the small bowel, where it interacts with gut-homing B and T cells expressing its receptor, CCR9. |
Recombinant Human CCL25 |
|||
Z101529 | ABM | 1.0 mg | EUR 3900 |
Description: CCL25 is constitutively expressed in epithelium and mucosal vessels in the small bowel, where it interacts with gut-homing B and T cells expressing its receptor, CCR9. |
Recombinant human CCL1 |
|||
P2046 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human CCL1 |
Recombinant Human CCL2 |
|||
P0160 | FN Test | 100ug | EUR 626.83 |
Description: Recombinant Human protein for CCL2 |
Recombinant Human CCL5 |
|||
EPT210 | ELK Biotech | 10ug | EUR 131.4 |
Description: Recombinant Human C-C Motif Chemokine 5 is produced by our E.coli expression system and the target gene encoding Ser24-Ser91 is expressed. |
Recombinant Human CCL2 |
|||
Z100625 | ABM | 20 µg | EUR 85 |
Description: MCP-1 belongs to the family of chemotactic cytokines. MCP-1 is expressed by monocytes, vascular endothelial cells, smooth muscle cells, glomerular mesangial cell, and osteoblastic cells. MCP-1 has been shown to exhibit biological activities other than chemotaxis. It can induce the proliferation and activation of killer cells known as CHAK. Elevated levels of MCP-1 are observed in atherosclerotic plaques that are rich in macrophages. The factor activates the tumoricidal activity of monocytes and macrophages in vivo. It regulates the expression of cell surface antigens (CD11c, CD11b) and the expression of cytokines (IL-1, IL-6). MCP-1 is a potent activator of human basophils, inducing degranulation and the release of histamines. In basophils activated by IL-3, IL-5 or GM-CSF MCP-1 enhances the synthesis of leukotriene C4. |
Recombinant Human CCL2 |
|||
Z100627 | ABM | 100 µg | EUR 295 |
Description: MCP-1 belongs to the family of chemotactic cytokines. MCP-1 is expressed by monocytes, vascular endothelial cells, smooth muscle cells, glomerular mesangial cell, and osteoblastic cells. MCP-1 has been shown to exhibit biological activities other than chemotaxis. It can induce the proliferation and activation of killer cells known as CHAK. Elevated levels of MCP-1 are observed in atherosclerotic plaques that are rich in macrophages. The factor activates the tumoricidal activity of monocytes and macrophages in vivo. It regulates the expression of cell surface antigens (CD11c, CD11b) and the expression of cytokines (IL-1, IL-6). MCP-1 is a potent activator of human basophils, inducing degranulation and the release of histamines. In basophils activated by IL-3, IL-5 or GM-CSF MCP-1 enhances the synthesis of leukotriene C4. |
Recombinant Human CCL2 |
|||
Z100629 | ABM | 1.0 mg | EUR 2025 |
Description: MCP-1 belongs to the family of chemotactic cytokines. MCP-1 is expressed by monocytes, vascular endothelial cells, smooth muscle cells, glomerular mesangial cell, and osteoblastic cells. MCP-1 has been shown to exhibit biological activities other than chemotaxis. It can induce the proliferation and activation of killer cells known as CHAK. Elevated levels of MCP-1 are observed in atherosclerotic plaques that are rich in macrophages. The factor activates the tumoricidal activity of monocytes and macrophages in vivo. It regulates the expression of cell surface antigens (CD11c, CD11b) and the expression of cytokines (IL-1, IL-6). MCP-1 is a potent activator of human basophils, inducing degranulation and the release of histamines. In basophils activated by IL-3, IL-5 or GM-CSF MCP-1 enhances the synthesis of leukotriene C4. |
Recombinant Human CCL3 |
|||
Z100675 | ABM | 20 µg | EUR 85 |
Description: Macrophage Inflammatory Protein-1 is a factor produced by macrophages that causes local inflammatory responses, and induces superoxide production by neutrophils. Two peptides are responsible for this activity. They have been termed MIP-1-alpha, and MIP-1-beta. The two MIP proteins are the major factors produced by macrophages following their stimulation with bacterial endotoxins. Both proteins are involved in the cell activation of human granulocytes (neutrophils, eosinophils, and basophils) and appear to be involved in acute neutrophilic inflammation. Both forms of MIP-1 stimulate the production of reactive oxygen species in neutrophils and the release of lysosomal enzymes. They also induce the synthesis of other pro-inflammatory cytokines such as IL-1, IL-6 and TNF in fibroblasts and macrophages. MIP-1-alpha is a potent agonist of basophils, inducing a rapid change of cytosolic free calcium (see also: Calcium ionophore), the release of histamine and sulfido- leukotrienes, and chemotaxis. Murine MIP-1- alpha is the primary stimulator of TNF secretion by macrophages, whereas MIP-1-beta antagonizes the inductive effects of MIP-1- alpha. In human monocytes the production of MIP-1-beta can be induced by bacterial lipopolysaccharides and IL-7. The biological activities of MIP-1-alpha and MIP-1-beta are mediated by receptors that bind both factors CCR5. A second species of receptors for these two factors also appears to bind MCAF. |
Recombinant Human CCL3 |
|||
Z100677 | ABM | 100 µg | EUR 295 |
Description: Macrophage Inflammatory Protein-1 is a factor produced by macrophages that causes local inflammatory responses, and induces superoxide production by neutrophils. Two peptides are responsible for this activity. They have been termed MIP-1-alpha, and MIP-1-beta. The two MIP proteins are the major factors produced by macrophages following their stimulation with bacterial endotoxins. Both proteins are involved in the cell activation of human granulocytes (neutrophils, eosinophils, and basophils) and appear to be involved in acute neutrophilic inflammation. Both forms of MIP-1 stimulate the production of reactive oxygen species in neutrophils and the release of lysosomal enzymes. They also induce the synthesis of other pro-inflammatory cytokines such as IL-1, IL-6 and TNF in fibroblasts and macrophages. MIP-1-alpha is a potent agonist of basophils, inducing a rapid change of cytosolic free calcium (see also: Calcium ionophore), the release of histamine and sulfido- leukotrienes, and chemotaxis. Murine MIP-1- alpha is the primary stimulator of TNF secretion by macrophages, whereas MIP-1-beta antagonizes the inductive effects of MIP-1- alpha. In human monocytes the production of MIP-1-beta can be induced by bacterial lipopolysaccharides and IL-7. The biological activities of MIP-1-alpha and MIP-1-beta are mediated by receptors that bind both factors CCR5. A second species of receptors for these two factors also appears to bind MCAF. |
Recombinant Human CCL3 |
|||
Z100679 | ABM | 1.0 mg | EUR 1440 |
Description: Macrophage Inflammatory Protein-1 is a factor produced by macrophages that causes local inflammatory responses, and induces superoxide production by neutrophils. Two peptides are responsible for this activity. They have been termed MIP-1-alpha, and MIP-1-beta. The two MIP proteins are the major factors produced by macrophages following their stimulation with bacterial endotoxins. Both proteins are involved in the cell activation of human granulocytes (neutrophils, eosinophils, and basophils) and appear to be involved in acute neutrophilic inflammation. Both forms of MIP-1 stimulate the production of reactive oxygen species in neutrophils and the release of lysosomal enzymes. They also induce the synthesis of other pro-inflammatory cytokines such as IL-1, IL-6 and TNF in fibroblasts and macrophages. MIP-1-alpha is a potent agonist of basophils, inducing a rapid change of cytosolic free calcium (see also: Calcium ionophore), the release of histamine and sulfido- leukotrienes, and chemotaxis. Murine MIP-1- alpha is the primary stimulator of TNF secretion by macrophages, whereas MIP-1-beta antagonizes the inductive effects of MIP-1- alpha. In human monocytes the production of MIP-1-beta can be induced by bacterial lipopolysaccharides and IL-7. The biological activities of MIP-1-alpha and MIP-1-beta are mediated by receptors that bind both factors CCR5. A second species of receptors for these two factors also appears to bind MCAF. |
Recombinant Human MEC(CCL28) |
|||
HECCP-2801 | Cyagen | 5ug | Ask for price |
Recombinant Human LEC (CCL16) |
|||
Z100325 | ABM | 25 µg | EUR 235 |
Description: CCL16 is a CC chemokine that specifically attracts lymphocytes, dendritic cells, and monocytes; increases their adhesive properties and has myelosuppressive activity. It is constitutively expressed in liver and is increased by interleukin 10 (IL-10) in activated monocytes. CCL16 is present in human plasma suggesting that it may be active outside hepatic tissue. CCR1, CCR2, CCR5, and CCR8 are the functional receptors of this chemokine. |
Recombinant Human LEC (CCL16) |
|||
Z100329 | ABM | 1.0 mg | EUR 3900 |
Description: CCL16 is a CC chemokine that specifically attracts lymphocytes, dendritic cells, and monocytes; increases their adhesive properties and has myelosuppressive activity. It is constitutively expressed in liver and is increased by interleukin 10 (IL-10) in activated monocytes. CCL16 is present in human plasma suggesting that it may be active outside hepatic tissue. CCR1, CCR2, CCR5, and CCR8 are the functional receptors of this chemokine. |
Recombinant Human MEC (CCL28) |
|||
Z101025 | ABM | 20 µg | EUR 235 |
Description: The mucosa-associated epithelial chemokine CCL28 is a common mucosal chemokine which is constitutively expressed by epithelial cells in most mucosal sites. Both CCL28 and CCL25 have recently been shown to be essential for lymphocyte migration to gastrointestinal tissues. CCL28 attracts IgA ASC, but not IgG or IgM ASC, from both intestinal and extraintestinal mucosal tissue, while CCL25 preferentially attracts IgA ASC from the small intestine and its draining lymphoid tissues, as well as alpha-4-beta-7(+) T cells. |
Recombinant Human MEC (CCL28) |
|||
Z101029 | ABM | 1.0 mg | EUR 3900 |
Description: The mucosa-associated epithelial chemokine CCL28 is a common mucosal chemokine which is constitutively expressed by epithelial cells in most mucosal sites. Both CCL28 and CCL25 have recently been shown to be essential for lymphocyte migration to gastrointestinal tissues. CCL28 attracts IgA ASC, but not IgG or IgM ASC, from both intestinal and extraintestinal mucosal tissue, while CCL25 preferentially attracts IgA ASC from the small intestine and its draining lymphoid tissues, as well as alpha-4-beta-7(+) T cells. |
CCL16, human recombinant |
|||
4349-1000 | Biovision | each | EUR 5540.4 |
CCL16, human recombinant |
|||
4349-20 | Biovision | each | EUR 307.2 |
CCL21, human recombinant |
|||
7338-50 | Biovision | each | EUR 548.4 |
Recombinant Human CCL21 Protein |
|||
RP01402 | Abclonal | 50μg | EUR 97.5 |
Recombinant Human TARC (CCL17) |
|||
HECCP-1701 | Cyagen | 5ug | Ask for price |
Recombinant Human TECK (CCL25) |
|||
HECCP-2501 | Cyagen | 5ug | Ask for price |
Recombinant Human TARC (CCL17) |
|||
Z100835 | ABM | 20 µg | EUR 180 |
Description: Thymus and activation-regulated chemokine (TARC) is a recently identified CC chemokine that is expressed constitutively in the thymus and transiently in stimulated peripheral blood mononuclear cells. TARC functions as a selective chemoattractant for T cells that express a class of receptors binding TARC with high affinity and specificity. The chemokine TARC is a ligand for the chemokine receptor CCR4 expressed on CD4 Th2 cells. |
Recombinant Human TARC (CCL17) |
|||
Z100839 | ABM | 1.0 mg | EUR 3000 |
Description: Thymus and activation-regulated chemokine (TARC) is a recently identified CC chemokine that is expressed constitutively in the thymus and transiently in stimulated peripheral blood mononuclear cells. TARC functions as a selective chemoattractant for T cells that express a class of receptors binding TARC with high affinity and specificity. The chemokine TARC is a ligand for the chemokine receptor CCR4 expressed on CD4 Th2 cells. |
Recombinant Human CTACK (CCL27) |
|||
7-01801 | CHI Scientific | 5µg | Ask for price |
Recombinant Human CTACK (CCL27) |
|||
7-01802 | CHI Scientific | 20µg | Ask for price |
Recombinant Human CTACK (CCL27) |
|||
7-01803 | CHI Scientific | 1mg | Ask for price |
Recombinant Human CTACK/CCL27 |
|||
HECCP-2701 | Cyagen | 5ug | Ask for price |
Recombinant Human CTACK (CCL27) |
|||
Z101885 | ABM | 20 µg | EUR 195 |
Description: CCL27 is a CC family chemokine which is expressed in epithelial cells and known to be up-regulated by inflammatory stimuli/wounded skin. CCL27 partakes in inflammation and wound healing – by selectively attracting and directing CLA+ T cells into the skin, and inducing the migration of keratinocyte precursors from bone marrow to the skin. High levels of this chemokine in human serum though, have been linked to the severity of various diseases, one being atopic dermatitis. |
Recombinant Human CTACK (CCL27) |
|||
Z101889 | ABM | 1.0 mg | EUR 3900 |
Description: CCL27 is a CC family chemokine which is expressed in epithelial cells and known to be up-regulated by inflammatory stimuli/wounded skin. CCL27 partakes in inflammation and wound healing – by selectively attracting and directing CLA+ T cells into the skin, and inducing the migration of keratinocyte precursors from bone marrow to the skin. High levels of this chemokine in human serum though, have been linked to the severity of various diseases, one being atopic dermatitis. |
Recombinant Human Eotaxin (CCL11) |
|||
7-01819 | CHI Scientific | 5µg | Ask for price |
Recombinant Human Eotaxin (CCL11) |
|||
7-01820 | CHI Scientific | 20µg | Ask for price |
Recombinant Human Eotaxin (CCL11) |
|||
7-01821 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Eotaxin(CCL11) |
|||
HECCP-1101 | Cyagen | 5ug | Ask for price |
Recombinant Human Eotaxin (CCL11) |
|||
CSB-EP004775HU | Cusabio | 748 mg | Ask for price |
Recombinant Human Eotaxin (CCL11) |
|||
Z100175 | ABM | 20 µg | EUR 85 |
Description: Eotaxin belongs to the platelet factor-4 family of chemokines. The gene symbol is SCYA11. The factor is being referred to also as Eotaxin-1 and has been renamed CCL11. Eotaxin induces substantial accumulation of eosinophils in the skin without significantly affecting the accumulation of neutrophils. Eotaxin is a potent stimulator of both guinea pig and human eosinophils in vitro. The Eotaxin receptor is a G-protein-coupled receptor selectively expressed in human eosinophils. |
Recombinant Human Eotaxin (CCL11) |
|||
Z100179 | ABM | 1.0 mg | EUR 2025 |
Description: Eotaxin belongs to the platelet factor-4 family of chemokines. The gene symbol is SCYA11. The factor is being referred to also as Eotaxin-1 and has been renamed CCL11. Eotaxin induces substantial accumulation of eosinophils in the skin without significantly affecting the accumulation of neutrophils. Eotaxin is a potent stimulator of both guinea pig and human eosinophils in vitro. The Eotaxin receptor is a G-protein-coupled receptor selectively expressed in human eosinophils. |
Recombinant Human Eotaxin(CCL11) |
|||
AP76786 | SAB | 1mg | EUR 1978 |
Recombinant Human Eotaxin/CCL11 |
|||
AP60304 | SAB | 100ug | EUR 896 |
Recombinant Human HCC-1 (CCL14) |
|||
7-01894 | CHI Scientific | 2µg | Ask for price |
Recombinant Human HCC-1 (CCL14) |
|||
7-01895 | CHI Scientific | 10µg | Ask for price |
Recombinant Human HCC-1 (CCL14) |
|||
7-01896 | CHI Scientific | 1mg | Ask for price |
Recombinant Human MCP-4 (CCL13) |
|||
HECCP-1301 | Cyagen | 5ug | Ask for price |
Recombinant Human HCC-1 (CCL14) |
|||
HECCP-1401 | Cyagen | 10ug | Ask for price |
Recombinant Human MIP-5 (CCL15) |
|||
HECCP-1501 | Cyagen | 5ug | Ask for price |
Recombinant Human MIP-4 (CCL18) |
|||
HECCP-1801 | Cyagen | 10ug | Ask for price |
Recombinant Human MDC/CCL22(69a.a.) |
|||
HECCP-2201 | Cyagen | 5ug | Ask for price |
Recombinant Human MIP-3 (CCL23) |
|||
HECCP-2301 | Cyagen | 5ug | Ask for price |
Recombinant Human HCC-1 (CCL14) |
|||
Z100305 | ABM | 10 µg | EUR 85 |
Description: Hemofiltrate C-C chemokine (HCC)-1 is a recently described monocyte chemoattractant. CCL14 (also known as HCC-1) belongs to the CC chemokine family. Its mature propeptide is a low-affinity agonist of CCR1 that is converted to a high-affinity agonist of CCR1 and CCR5 on proteolytic processing by serine proteases. Determination of the amino acid sequence of HCC-1 revealed four cysteine residues in positions characteristic of the C-C chemokine family, and comparison with the sequences of other chemokines revealed that HCC-1 was most homologous to MIP-1a. However, several functional properties of HCC-1 were atypical of chemokines. Unlike other chemokines, HCC-1 was expressed constitutively in a number of tissues and was present at high concentrations in normal human plasma. In addition, HCC-1 was reported not to be chemotactic for leukocytes. |
Recombinant Human HCC-1 (CCL14) |
|||
Z100307 | ABM | 100 µg | EUR 300 |
Description: Hemofiltrate C-C chemokine (HCC)-1 is a recently described monocyte chemoattractant. CCL14 (also known as HCC-1) belongs to the CC chemokine family. Its mature propeptide is a low-affinity agonist of CCR1 that is converted to a high-affinity agonist of CCR1 and CCR5 on proteolytic processing by serine proteases. Determination of the amino acid sequence of HCC-1 revealed four cysteine residues in positions characteristic of the C-C chemokine family, and comparison with the sequences of other chemokines revealed that HCC-1 was most homologous to MIP-1a. However, several functional properties of HCC-1 were atypical of chemokines. Unlike other chemokines, HCC-1 was expressed constitutively in a number of tissues and was present at high concentrations in normal human plasma. In addition, HCC-1 was reported not to be chemotactic for leukocytes. |
Recombinant Human HCC-1 (CCL14) |
|||
Z100309 | ABM | 1.0 mg | EUR 1200 |
Description: Hemofiltrate C-C chemokine (HCC)-1 is a recently described monocyte chemoattractant. CCL14 (also known as HCC-1) belongs to the CC chemokine family. Its mature propeptide is a low-affinity agonist of CCR1 that is converted to a high-affinity agonist of CCR1 and CCR5 on proteolytic processing by serine proteases. Determination of the amino acid sequence of HCC-1 revealed four cysteine residues in positions characteristic of the C-C chemokine family, and comparison with the sequences of other chemokines revealed that HCC-1 was most homologous to MIP-1a. However, several functional properties of HCC-1 were atypical of chemokines. Unlike other chemokines, HCC-1 was expressed constitutively in a number of tissues and was present at high concentrations in normal human plasma. In addition, HCC-1 was reported not to be chemotactic for leukocytes. |
Recombinant Human HCC-2 (CCL15) |
|||
Z100315 | ABM | 25 µg | EUR 85 |
Description: CCL15 is a human chemokine which acts predominantly on chemokine receptor CCR1 and to a lesser degree on CCR3. It is a potent chemoattractant for monocytes and lymphocytes in vitro and, after i.p. application, CCL15 induces recruitment neutrophils, monocytes, and lymphocytes into mouse peritoneum. CCL15 is constitutively expressed in the gut and in the liver and was identified to circulate in human plasma. The N-terminus of CCL15 was found to be important to exert its full biological activity. HCC-2 shares significant sequence homology with CKb8 and the murine chemokines C10, CCF18/MRP-2, and macrophage inflammatory protein 1g, which all contain six instead of four conserved cysteines. |
Recombinant Human HCC-2 (CCL15) |
|||
Z100319 | ABM | 1.0 mg | EUR 2260 |
Description: CCL15 is a human chemokine which acts predominantly on chemokine receptor CCR1 and to a lesser degree on CCR3. It is a potent chemoattractant for monocytes and lymphocytes in vitro and, after i.p. application, CCL15 induces recruitment neutrophils, monocytes, and lymphocytes into mouse peritoneum. CCL15 is constitutively expressed in the gut and in the liver and was identified to circulate in human plasma. The N-terminus of CCL15 was found to be important to exert its full biological activity. HCC-2 shares significant sequence homology with CKb8 and the murine chemokines C10, CCF18/MRP-2, and macrophage inflammatory protein 1g, which all contain six instead of four conserved cysteines. |
Recombinant Human MCP-4 (CCL13) |
|||
Z100645 | ABM | 25 µg | EUR 85 |
Description: Monocyte Chemoattractant Proteins 4 (MCP-4/CCL13) is member of a distinct, structurally-related subclass of CC chemokines. MCP-4/CCL13 is a major chemoattractants for eosinophils, basophils, monocytes, and T lymphocytes. The MCP protein family bind to specific G-protein-coupled receptors, initiating a signal cascade within the cell. Expression of MCP-4/CCL13 mRNA and protein is greater in the sputum, epithelium, submucosal inflammatory cells, and bronchoalveolar lavage fluid of asthmatics than in healthy individuals. Involvement of MCPs has also been demonstrated in renal inflammation and atopic dermatitis. The expression of this protein is also correlated with enhanced inflammatory immune responses during immunotherapy. The recombinant construct corresponds to the “short-chain” of CCL13 spanning amino acids 24 – 98. |
Recombinant Human MCP-4 (CCL13) |
|||
Z100647 | ABM | 100 µg | EUR 255 |
Description: Monocyte Chemoattractant Proteins 4 (MCP-4/CCL13) is member of a distinct, structurally-related subclass of CC chemokines. MCP-4/CCL13 is a major chemoattractants for eosinophils, basophils, monocytes, and T lymphocytes. The MCP protein family bind to specific G-protein-coupled receptors, initiating a signal cascade within the cell. Expression of MCP-4/CCL13 mRNA and protein is greater in the sputum, epithelium, submucosal inflammatory cells, and bronchoalveolar lavage fluid of asthmatics than in healthy individuals. Involvement of MCPs has also been demonstrated in renal inflammation and atopic dermatitis. The expression of this protein is also correlated with enhanced inflammatory immune responses during immunotherapy. The recombinant construct corresponds to the “short-chain” of CCL13 spanning amino acids 24 – 98. |
Recombinant Human MCP-4 (CCL13) |
|||
Z100649 | ABM | 1.0 mg | EUR 2025 |
Description: Monocyte Chemoattractant Proteins 4 (MCP-4/CCL13) is member of a distinct, structurally-related subclass of CC chemokines. MCP-4/CCL13 is a major chemoattractants for eosinophils, basophils, monocytes, and T lymphocytes. The MCP protein family bind to specific G-protein-coupled receptors, initiating a signal cascade within the cell. Expression of MCP-4/CCL13 mRNA and protein is greater in the sputum, epithelium, submucosal inflammatory cells, and bronchoalveolar lavage fluid of asthmatics than in healthy individuals. Involvement of MCPs has also been demonstrated in renal inflammation and atopic dermatitis. The expression of this protein is also correlated with enhanced inflammatory immune responses during immunotherapy. The recombinant construct corresponds to the “short-chain” of CCL13 spanning amino acids 24 – 98. |
Recombinant Human MIP-3 (CCL23) |
|||
Z100695 | ABM | 20 µg | EUR 85 |
Description: CCL23 (MPIF-1, CK8, SCYA23), a member of the CC chemokine family, was originally isolated from a human aortic endothelial cell library and from the human monocytic cell line THP-1. It is most closely related to MIP-1 and interacts with its receptor CCR1, which is expressed on monocytes, dendritic cells, lymphocytes, and endothelial cells. Functionally, CCL23 has chemotactic activity for monocytes, DC, lymphocytes, neutrophils, osteoclast precursor cells, and endothelial cells. In contrast, CCL23 reduces the proliferation of progenitor cells giving rise to granulocyte and monocyte lineages, whereas it enhances angiogenesis of endothelial cells |
Recombinant Human MIP-3 (CCL23) |
|||
Z100697 | ABM | 100 µg | EUR 295 |
Description: CCL23 (MPIF-1, CK8, SCYA23), a member of the CC chemokine family, was originally isolated from a human aortic endothelial cell library and from the human monocytic cell line THP-1. It is most closely related to MIP-1 and interacts with its receptor CCR1, which is expressed on monocytes, dendritic cells, lymphocytes, and endothelial cells. Functionally, CCL23 has chemotactic activity for monocytes, DC, lymphocytes, neutrophils, osteoclast precursor cells, and endothelial cells. In contrast, CCL23 reduces the proliferation of progenitor cells giving rise to granulocyte and monocyte lineages, whereas it enhances angiogenesis of endothelial cells |
Recombinant Human MIP-3 (CCL23) |
|||
Z100699 | ABM | 1.0 mg | EUR 2025 |
Description: CCL23 (MPIF-1, CK8, SCYA23), a member of the CC chemokine family, was originally isolated from a human aortic endothelial cell library and from the human monocytic cell line THP-1. It is most closely related to MIP-1 and interacts with its receptor CCR1, which is expressed on monocytes, dendritic cells, lymphocytes, and endothelial cells. Functionally, CCL23 has chemotactic activity for monocytes, DC, lymphocytes, neutrophils, osteoclast precursor cells, and endothelial cells. In contrast, CCL23 reduces the proliferation of progenitor cells giving rise to granulocyte and monocyte lineages, whereas it enhances angiogenesis of endothelial cells |
Recombinant Human MIP-4 (CCL18) |
|||
Z100715 | ABM | 10 µg | EUR 85 |
Description: CCL18, also designated dendritic cell (DC)3-derived CC chemokine 1, pulmonary and activation-regulated chemokine, alternative macrophage activation-associated CC chemokine 1, and MIP-4, is a human chemokine structurally related to CCL3. CCL18 was shown to be expressed in germinal centers of tonsils by dendritic cells and to attract mainly naive T cells, CD38 mantle zone B lymphocytes and DC. The production of CCL18 by APC is enhanced by Th2 cytokines like IL-4 and IL-13 and suppressed by IFN-gamma. |
Recombinant Human MIP-4 (CCL18) |
|||
Z100717 | ABM | 100 µg | EUR 360 |
Description: CCL18, also designated dendritic cell (DC)3-derived CC chemokine 1, pulmonary and activation-regulated chemokine, alternative macrophage activation-associated CC chemokine 1, and MIP-4, is a human chemokine structurally related to CCL3. CCL18 was shown to be expressed in germinal centers of tonsils by dendritic cells and to attract mainly naive T cells, CD38 mantle zone B lymphocytes and DC. The production of CCL18 by APC is enhanced by Th2 cytokines like IL-4 and IL-13 and suppressed by IFN-gamma. |
Recombinant Human MIP-4 (CCL18) |
|||
Z100719 | ABM | 1.0 mg | EUR 1500 |
Description: CCL18, also designated dendritic cell (DC)3-derived CC chemokine 1, pulmonary and activation-regulated chemokine, alternative macrophage activation-associated CC chemokine 1, and MIP-4, is a human chemokine structurally related to CCL3. CCL18 was shown to be expressed in germinal centers of tonsils by dendritic cells and to attract mainly naive T cells, CD38 mantle zone B lymphocytes and DC. The production of CCL18 by APC is enhanced by Th2 cytokines like IL-4 and IL-13 and suppressed by IFN-gamma. |
MEC/CCL28, human recombinant |
|||
7170-10 | Biovision | each | EUR 248.4 |
MEC/CCL28, human recombinant |
|||
7170-50 | Biovision | each | EUR 810 |
Recombinant Human CCL17/TARC Protein |
|||
RP01374 | Abclonal | 20μg | EUR 39 |
Recombinant Human CCL17/TARC Protein |
|||
RP00315 | Abclonal | 10 μg | EUR 196.8 |
Recombinant Human CCL18/PARC Protein |
|||
RP00810 | Abclonal | 10 μg | EUR 265.2 |
TECK (CCL25), human recombinant |
|||
7214-10 | Biovision | each | EUR 248.4 |
TECK (CCL25), human recombinant |
|||
7214-50 | Biovision | each | EUR 810 |
CCL3L1, human recombinant |
|||
7305-100 | Biovision | each | EUR 444 |
Recombinant Human Exodus-2 (CCL21) |
|||
7-01840 | CHI Scientific | 5µg | Ask for price |
We evaluation the results on copying the kinetics of nucleotides with altered nucleobase and sugar moieties, when they’re current as activated monomers and when they’re included into primer and template oligonucleotides. We additionally talk about three variations in spine connectivity, all of that are nonheritable and regenerate native RNA upon being copied. The kinetic superiority of RNA synthesis means that nonenzymatic copying served as a chemical choice mechanism that allowed comparatively homogeneous RNA to emerge from a posh combination of prebiotically synthesized nucleotides and oligonucleotides.